| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/18/2009 | US20090155273 Remedies for inflammatory bowel diseases |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155201 Alkylated poly(allylamine) polymers and methods of use |
| 06/18/2009 | US20090155193 Topical Bioadhesive Formulations |
| 06/18/2009 | US20090155186 Compositions and methods for treating inflammatory conditions |
| 06/18/2009 | CA2709301A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/18/2009 | CA2707981A1 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 06/18/2009 | CA2707679A1 Agent for treating ulcer |
| 06/18/2009 | CA2706811A1 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2070927A1 Fused heterocyclic derivative |
| 06/17/2009 | EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070920A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 06/17/2009 | EP2070919A1 Spiroquinone compound and pharmaceutical composition |
| 06/17/2009 | EP2070551A1 Improved thickened beverages for dysphagia |
| 06/17/2009 | EP2070545A1 Oral compositions for the prevention and treatment of inflammatory disorders of the colon |
| 06/17/2009 | EP2070541A1 Promoter of hard tissue regeneration |
| 06/17/2009 | EP2070530A1 Treatment of diseases associated with the use of antibiotics |
| 06/17/2009 | EP2070528A1 Method for absorbing odours |
| 06/17/2009 | EP2069329A2 A process for the preparation of benzimidazole derivatives and their salts |
| 06/17/2009 | EP1871381B1 Therapeutic substituted cyclopentanones |
| 06/17/2009 | EP1499616B1 Heterocyclic compounds |
| 06/17/2009 | EP1491204B1 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | EP1322592B2 Substituted 1-aminobutan-3-ol derivatives |
| 06/17/2009 | EP1267883B1 Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin |
| 06/17/2009 | CN100500669C Salviolic acid berberine compound salt, its preparation method and application |
| 06/17/2009 | CN100500181C Capsules of Moyuqing for regulating digestive function |
| 06/17/2009 | CN100500148C A buffered, liquid nicotine composition for pulmonary administration |
| 06/17/2009 | CN100500147C New formulations and use thereof |
| 06/17/2009 | CN100500020C Concentrated solution of acanthopanax root, royal jelly, pollen and honey and method for making it |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 06/16/2009 | US7547451 Comprises core and enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a derivative thereof; treatment of ulcerative colitis and Crohn's disease |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2357744C Potassium salt of (s)-omeprazole |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2330500C Pharmaceutical compositions capable of being gelled |
| 06/11/2009 | WO2009073648A2 Compositions and methods for regulating entamoeba histolytica function |
| 06/11/2009 | WO2009072674A1 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same |
| 06/11/2009 | WO2009072643A1 Nitrogen-containing heterocyclic compound and use thereof |
| 06/11/2009 | WO2009072594A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/11/2009 | WO2009072527A1 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 06/11/2009 | WO2009071993A2 Pharmaceutical compositon for cleansing of the bowel |
| 06/11/2009 | WO2009071988A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 06/11/2009 | WO2009071578A1 Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality |
| 06/11/2009 | WO2009071161A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | WO2009019255A3 Synergetic composition comprising flavouring substances and organic acids and use thereof |
| 06/11/2009 | WO2008140565A3 Use of tumor necrosis factor receptor 14 antagonists for treating psoriasis |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149537 Use of Bile Acid or Bile Salt Fatty Acid Conjugates |
| 06/11/2009 | US20090149535 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |
| 06/11/2009 | US20090149498 Pharmaceutical composition having prokinetic effect |
| 06/11/2009 | US20090149474 tert-butyl 4-[(4-chlorobenzoyl)amino]-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, used for the treatment of gastrointestinal disorders such as gastroesophageal reflux, irritable bowel syndrome, dyspepsia, diarrhea and for the inhibition of transient lower esophageal sphincter relaxations |
| 06/11/2009 | US20090149465 Aminotetralin compounds as mu opioid receptor antagonists |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149431 Eplerenone Drug Substance Having High Phase Purity |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090148538 Use of adsorbent carbon microspheres to treat pouchitis |
| 06/11/2009 | US20090148530 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| 06/11/2009 | US20090148524 Method of producing solid preparation disintegrating in the oral cavity |
| 06/11/2009 | US20090148480 Sustained release preparation |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148413 Method for treatment of irritable bowel syndrome |
| 06/11/2009 | US20090148409 For improving the health of a companion animal; reducing pathogenic bacteria in feces, reducing stress, autoimmune disease, aging, kidney stones |
| 06/11/2009 | US20090148397 Compositions and Methods of Treatment With Proanthocyanidin Polymer Antidiarrheal Compositions |
| 06/11/2009 | CA2707823A1 A stable docusate pharmaceutical composition |
| 06/11/2009 | CA2707585A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | CA2705780A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/10/2009 | EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067476A1 The application of glycyrrhizic acid and its breakdown product glycyrrhetinic acid for the manufacture of a medicament for the treatment of inflammatory bowel disease |
| 06/10/2009 | EP2066658A1 Pyridine- and quinoline-pyrimidine-derivatives |
| 06/10/2009 | EP2066304A2 Systems, methods and compositions for treatment and use of a palatal patch |
| 06/10/2009 | EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | EP1135122B1 Use of amtolmetin guacyl as for the treatment of intestinal inflammations |
| 06/10/2009 | EP0831892B1 Multimeric, recombinant urease vaccine |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100497577C Kidney tonic hygienic wine and its preparation |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497391C Humanized gene engineering antibody resisting hepatitis E virus |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497385C Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome |
| 06/10/2009 | CN100497356C Crystalline forms of adefovir dipivoxil ester |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496607C Combination of a NSAID and a PDE-4 inhibitor |
| 06/10/2009 | CN100496568C Jin-Gui-Shen-Qi capsule preparation method |
| 06/10/2009 | CN100496566C Medicine for quickly treating gall and stomach disease |